Facebook WhatsApp TAGS Pinterest Twitter Twitter Previous articleEHR Concepts Offering Healthcare IT Helpdesk ServicesNext articleTrust the Leaders in Online School: Hoosier Academies and Insight School of Indiana Now Accepting Enrollments for 2021-2022 School Year Digital AIM Web Support Local NewsBusiness Facebook By Digital AIM Web Support – April 6, 2021 Yokogawa e ICQ Consultans firmam acordo de parceria para negócios biofarmacêuticos Pinterest WhatsApp TÓQUIO E SOUTHBOROUGH, Massachusetts–(BUSINESS WIRE)–fev 24, 2021– A Yokogawa Electric Corporation (TOKYO: 6841) (Yokogawa) e a Integrated Commissioning and Qualification Consultants Corp. (ICQ Consultants), de Southborough, anunciam que assinaram um acordo de parceria segundo o qual a ICQ Consultants fornecerá serviços de consultoria e engenharia para instalação, manutenção, qualificação e suporte dos sistemas de Biorreatores e produtos relacionados da Yokogawa nos Estados Unidos. Este comunicado de imprensa inclui multimédia. Veja o comunicado completo aqui: https://www.businesswire.com/news/home/20210223005035/pt/ Yokogawa’s Advanced Control Bioreactor System BR1000 (Photo: Business Wire) Como resultado da pandemia de COVID, o mercado biofarmacêutico global tem crescido a uma taxa sem precedentes, com investimentos significativos sendo feitos em diagnósticos, desenvolvimento de vacinas e dispositivos médicos para testar e tratar o coronavírus. Esses investimentos impulsionaram a demanda por infraestrutura no desenvolvimento e fabricação de medicamentos e produtos de anticorpos monoclonais que requerem tecnologias de Biorreatores de células de mamíferos. Desde 2007, a ICQ Consultants têm desempenhado um papel importante no comissionamento e qualificação de fábricas nos principais centros de Ciências da Vida nos Estados Unidos, incluindo algumas das maiores instalações de biofabricação do mundo. Como parte deste acordo de parceria, a Yokogawa irá alavancar a experiência de engenharia e laboratório da ICQ Consultants no segmento biofarmacêutico para implantar suas novas tecnologias de bioprocessos nos Estados Unidos. O primeiro produto do portfólio, o Advanced Control Bioreactor System BR1000, foi lançado recentemente em 8 de janeiro, oferecendo vantagens de desempenho significativas sobre os métodos existentes para desenvolvimento de produtos biológicos. A automação de processos manuais é uma tendência que avança rapidamente na indústria biofarmacêutica. Para a automação completa do processo de cultura de células de mamíferos em lote alimentado, o controle da glicose – uma fonte importante de nutrientes – é fundamental. Por meio de sensor em linha e software de controle preditivo de modelo e alimentação automatizada, uma concentração estável de glicose em Biorreatores pode ser alcançada. O BR1000 automatiza a cultura de células de mamíferos em escala de laboratório com monitoramento altamente preciso em tempo real e controle de processo avançado. Michael Bogan, presidente da ICQ Consultants, comentou: “Estamos muito entusiasmados em nos unir à Yokogawa neste acordo de parceria estratégica para ajudar a facilitar o suporte de seus sistemas de Biorreatores e produtos relacionados nos Estados Unidos. Com a expansão das operações da ICQ Consultants em todo o país, estamos preparados para desenvolver ainda mais relacionamentos duradouros, que têm sido um fator chave para nosso sucesso contínuo. Estou ansioso para trabalhar com a Yokogawa nesta oportunidade única e colaborativa.” Hiroshi Nakao, vice-presidente da Yokogawa e chefe da sede da empresa Life Innovation Business Headquarters, acrescentou: “Impulsionada por uma visão empresarial clara e sucessos recentes nos setores de ciências biológicas, alimentos e farmacêuticos, a Yokogawa Corporation of America também está voltando sua atenção para desenvolvimento e fabricação de produtos biológicos. As alianças com especialistas do setor, como a ICQ Consultants, são vitais para obter experiência e penetração no mercado biofarmacêutico de alto crescimento. O conhecimento técnico e de engenharia dos da ICQ Consultants na fabricação de medicamentos apoiará nosso novo biorreator e tecnologias de bioprocessos inovadores e ajudará a posicionar a Yokogawa para vendas rápidas e liderança de mercado no emergente setor de autonomia bioindustrial.” Para obter mais informações Controle Avançado do sistema biorreator BR1000 https://www.yokogawa.com/solutions/products-platforms/life-science/bioreactor/br1000/ Sobre a ICQ Consultants A ICQ Consultants faz parceria com empresas líderes e emergentes de biofarma e Ciências da Vida para ajudar as equipes de engenharia e qualidade a antecipar e resolver proativamente desafios complexos de comissionamento, qualificação e validação. O objetivo final da ICQ Consultants é facilitar a entrega segura e oportuna de medicamentos e terapias aos pacientes necessitados. Aplicando uma abordagem pragmática nada típica, a comunicação transparente e a filosofia de gerenciamento de projetos, em primeiro lugar, garantem o cumprimento estrito dos regulamentos do setor em constante evolução, requisitos específicos do local, cronogramas e orçamentos. A ICQ Consultans realiza atividades essenciais de comissionamento, qualificação e validação (CQV) e qualidade de maneira adequada para que as instalações do cliente possam se concentrar em salvar e melhorar a vida dos pacientes. Desde 2007, a ICQ Consultants tem parceria com os maiores fabricantes biofarmacêuticos do mundo e empresas emergentes de ciências biológicas para fornecer serviços abrangentes de comissionamento, qualificação e validação que aceleram a entrega de medicamentos e terapias aos pacientes necessitados. A ICQ Consultants também construiu e manteve um banco de dados crescente de mais de 500 profissionais de CQV avaliados por habilidades, permitindo aos clientes obter a combinação certa de habilidades e experiência para complementar as equipes internas de engenharia e conformidade. Sobre a Yokogawa Fundada em 1915, a Yokogawa desenvolve atividades abrangentes nas áreas de medição, controle e informação. O negócio de automação industrial oferece produtos, serviços e soluções essenciais a uma ampla variedade de indústrias de processo, incluindo óleo e gás, petróleo, produtos químicos, gás natural, energia, ferro e aço, bem como celulose e papel. Com o negócio de inovação da vida, a empresa procura melhorar radicalmente a produtividade nas cadeias de valor do setor farmacêutico e alimentício. Os negócios de teste e medição, aviação, entre outros, continuam a fornecer instrumentos e equipamentos essenciais com precisão e confiabilidade líderes do setor. A Yokogawa coinova com seus clientes através de uma rede global de 114 empresas em 62 países, alcançando US$ 3,7 bilhões em vendas no ano fiscal de 2019. Para obter informações adicionais, acesse www.yokogawa.com. Os nomes das empresas, organizações, produtos, serviços e logotipos mencionados neste texto são marcas registradas ou marcas comerciais da Yokogawa Electric Corporation ou de seus respectivos titulares. O texto no idioma original deste anúncio é a versão oficial autorizada. As traduções são fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que é a única versão do texto que tem efeito legal. Ver a versão original em businesswire.com:https://www.businesswire.com/news/home/20210223005035/pt/ CONTACT: Yokogawa Electric Corporation Relações públicas, Centro de Comunicação Integrada [email protected] Commissioning and Qualification Consultants, Corp. Michael Bogan, Presidente [email protected] KEYWORD: UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC MASSACHUSETTS INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL OTHER MANUFACTURING HARDWARE HEALTH MEDICAL DEVICES TECHNOLOGY MANUFACTURING SOURCE: Yokogawa Electric Corporation Copyright Business Wire 2021. PUB: 02/24/2021 02:00 AM/DISC: 02/24/2021 02:01 AM http://www.businesswire.com/news/home/20210223005035/pt
Today would have been Gregg Allman‘s 70th birthday. In celebration of his life and legacy, a new music video has been released from the final track of his posthumous album Southern Blood. The “Song For Adam” features a heartwarming collaboration with singer/songwriter Jackson Browne. Browne pays his homage in both blatant and subtle ways, from crafting a song perfect for Allman to providing harmonies on the song itself, essentially backing the icon while arming him with one last bullet.The emotional ballad is about two motorcyclist who are forced to say goodbye due to a sudden death, and is directed by Erica Silverman. Starring Zach Chance (of Jamestown Revival), Yates Robertson, Zoe Graham and Johnny McPhail, the video presents the relationship in both future and present moments–and inevitably pulls heart strings with the memories of Duane Allman and Berry Oakley, original members of the Allman Brothers Band who both passed away in motorcycle accidents within a year of each other.In an earlier interview with Rolling Stone, producer Don Was explained the song-picking process for “Song for Adam”, suggesting that Allman chose the song based on the memories of his late brother, Duane Allman, who died in a motorcycle at the age of 24. During the recording process, when Gregg got to the profound lyric, “Still it seems he stopped singing in the middle of his song,” it brought him to a place of emotion–and you can hear it on the recording of the final track. “He wasn’t able to finish the verse,” Was reflects. “He never got the last two lines. I know he was thinking about his brother. We all decided, ‘Let’s not fix it.’”Watch “Song For Adam” below:The passing of Gregg Allman was, as it is for us all, inescapable. The positive at the heart of the tragedy is that he left so many lives richer. Music can be a means of escape, a tool for healing, and an avenue to share feelings far easier than words could ever allow on their own. Through his songs and countless live performances, Allman worked to elevate the spirit while facing all that life could throw at him. Southern Blood, as a last thought on the human condition, is an emotional parting gift from a man who gave everything he could to us all.
Gov. Douglas Urges Congress to ‘Thoroughly’ InvestigateFuel Prices & Take Action The Vermont Fuel Dealers Association has called onCongress to close the “Enron loophole,” a provision that protectslargely unregulated “dark exchanges” and drives the price of fuelbased on speculation, rather than free market principles of supply and demand. Montpelier, Vt. – Governor Jim Douglastoday praised the U.S. Congress for holding hearings on skyrocketing oilprices, but urged lawmakers to conduct a “real, thoroughinvestigation.” Governor Douglas on several occasions has urged the U.S. Congress to begina bipartisan investigation of escalating fuel prices. The Governor and abipartisan group of 21 of his colleagues had called for a similar investigationlast May. The Governor most recently urged Congress to investigate oil pricesearlier this winter. “What’s troubling to average Americans is that as theprice of fuel continues to rise, oil companies are making record-settingprofits. I’m pleased the Congress is finally looking into this issue. It is my hope that they will go beyond hearings and conduct a real, thoroughinvestigation into what exactly is driving price increases and what can be doneto lower them,” Governor Douglas said. ### “High fuel prices hurt low and middle incomeVermonters the most. And while my administration will continue to hold theline on in-state proposals that would make fuel more expensive, a long-termsolution can only be achieved by the federal government,” GovernorDouglas said. “Americans deserve honest answers and real solutions tothis recurring and unresolved problem.” Jason GibbsGovernor’sCommunications Director109 State Street ¨ The Pavilion ¨ Montpelier,VT 05609-0101 ¨ www.vermont.gov/governor(link is external)Telephone: 802.828.3333 ¨ Fax: 802.828.3339 ¨ TDD: 802.828.3345 Congress has the authority and the ability toinvestigate fuel costs and enact free market reforms that lower prices, the Governoradded.
Terry suffered a knee injury prior to Benitez’s appointment and a setback saw him miss the defeat of Wigan before he was an unused substitute, for a fifth time under the Spaniard, in the Europa League win at Sparta Prague. The former England captain could yet return to the bench for Thursday’s second leg with Sparta, with Sunday’s Barclays Premier League clash at Manchester City the priority as Benitez bids to fulfil his brief of Champions League football next term. Benitez, with a third successive win, continued to turn the momentum following three wins in the previous 10 games. Due to the Spaniard’s association with Liverpool, he will likely never be a popular appointment – be it on his current caretaker basis or permanently – but Benitez has Terry’s support. “If you are losing games, the pressure is on the manager,” Terry said. “He has to take responsibility because he is the one who picks the team. So if we are not [winning], as with all managers, it falls on his head, unfortunately. But if we are winning games, and hopefully we can do that, it takes the pressure off him.” Terry hopes to play his part in the season run-in, but knows he cannot demand a place in the side, given the form of Gary Cahill and Branislav Ivanovic, plus the option of David Luiz, who Benitez appears to view more as a defensive midfielder. “I’m not silly,” Terry added. “I’ve been out for four months – the other two guys have been playing really well, so it is going to be difficult for me to get back in. Naturally I want to play games; the manager doesn’t need to ask me that question to know what answer he is going to get. “I am not one to go in and knock the manager’s door down. I respect the other players. I have to fight for my place, the same as everyone. I think it is important that comes across from me directly.” Chelsea captain John Terry is adamant he is happy to sit on the substitutes’ bench, if it is what is best for the team. The 32-year-old defender on Sunday made just his third start under interim boss Rafael Benitez and scored the fourth goal as the FA Cup holders claimed a 4-0 win over Brentford to set up a fifth-round clash at Middlesbrough a week on Wednesday. “It is not about Rafa, me or Frank Lampard, it is not about anybody,” said Terry, who denied a report of a bust-up with Benitez. “It is about this football club winning games and if that’s with me in the side, great. If not, then I will be their biggest supporter and I’ll sit there and support the team like the fans will.” Press Association
Matt Donoghue knew he wanted to go to a university where he could be near the water and continue rowing. When he came to the University of Wisconsin four years ago after his senior year at St. Ignatius Prep in Chicago, he knew this was the right place for him.”I love the lake,” Donoghue said. “I love this campus and being on the lake.”Donoghue is in his fourth and final season as a member of the Badger men’s rowing team, and he is hoping to go out with a bang.”We’ve got a strong senior class,” Donoghue said. “When we came in here as freshmen, they had just graduated a strong senior class. So our freshman year the team was really down. But gradually over our four years, we’ve become better and better and are looking to finish strong.”Donoghue along with fellow seniors Andrew Kaufman, Ben Szymanski, Max Vice-Reshel and Scott Wallen were all members of the varsity eight last season. That boat finished fifth at the Eastern Sprints and ninth in the varsity eight at the IRA, which is the national championship of rowing. Overall, the Badgers finished sixth as a team at the IRA.There is no Big Ten conference when it comes to the sport of rowing. The Badgers compete in the EARC, the Eastern Association of Rowing, and the Eastern Sprints is the conference championship regatta.”Andy, Max and Scott were all members of the U-23 national team,” Donoghue said. “So having guys that can compete on an international level like that helps out our team tremendously.”With 12 seniors and 16 juniors all competing for eight spots in the varsity boat, Donoghue feels that this year could be a great year for Wisconsin rowing.”This year it will be much harder to make the top boat,” Donoghue said. “The team as a whole is much better. Everyone is pushing up. For us seniors, we know that this is our last chance to cement our legacy here at Wisconsin.”Donoghue spent much of his summer rowing with fellow teammate Derek Rasmussen. The boats that they raced never finished lower than third at several events, while the two of them won the pairs at nationals and Canadian Henley. With the summer over and the fall almost past, Donoghue and the Badgers have shown that they’ve got a pretty good start on the season. But with winter indoor conditioning yet to come, Donoghue knows everyone will still have to push themselves to have a successful spring season.”That’s the thing about rowing at Wisconsin,” Donoghue said. “We do a lot of indoor conditioning, but the facilities we have are great for the indoor stuff. Rowing has boomed in the Midwest within the last decade, and I would say that Wisconsin is the establishment of rowing in the Midwest.”With rowing a huge sport on both coasts, Donoghue says he is used to the stereotypes of Badger rowing.”The coastal schools are known for rowing, not the UW,” Donoghue said. “When we get the chance to race the teams from the coast we always want to beat them for a lot of reasons; not the least is that there is bit of a ‘state school vs. private’ thing going.Mainly though, we just want to win because that’s why we are in the game.”With the spring season not too far away, Donoghue believes this is the time for the Badgers.”The spring is huge for us,” the senior rower said. “We’ve got some big races before the Easterns and the IRA. This is the last shot for the seniors. If we are going to make a run, this is it. I don’t want to leave anything on the table or have any regrets; we’re all in.”